Compare CRMD & ATEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRMD | ATEX |
|---|---|---|
| Founded | 2006 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 605.9M | 597.4M |
| IPO Year | 2009 | 2014 |
| Metric | CRMD | ATEX |
|---|---|---|
| Price | $7.01 | $36.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | $15.29 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 1.9M | 550.1K |
| Earning Date | 04-10-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.03 | N/A |
| EPS | 1.97 | ★ 3.85 |
| Revenue | ★ $43,472,170.00 | $6,031,000.00 |
| Revenue This Year | $627.64 | $8.34 |
| Revenue Next Year | N/A | $4.32 |
| P/E Ratio | ★ $3.57 | $9.33 |
| Revenue Growth | ★ 66363.08 | 43.90 |
| 52 Week Low | $5.60 | $17.58 |
| 52 Week High | $17.43 | $39.62 |
| Indicator | CRMD | ATEX |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 77.63 |
| Support Level | $7.29 | $31.51 |
| Resistance Level | $7.74 | $36.74 |
| Average True Range (ATR) | 0.32 | 2.42 |
| MACD | 0.05 | 0.70 |
| Stochastic Oscillator | 1.99 | 96.80 |
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.